205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.55%
Revenue growth under 50% of QRVO's 23.79%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
10.73%
Gross profit growth at 50-75% of QRVO's 14.59%. Martin Whitman would question if cost structure or brand is lagging.
18.30%
EBIT growth below 50% of QRVO's 720.33%. Michael Burry would suspect deeper competitive or cost structure issues.
18.21%
Operating income growth under 50% of QRVO's 690.68%. Michael Burry would be concerned about deeper cost or sales issues.
5.92%
Net income growth under 50% of QRVO's 308.76%. Michael Burry would suspect the firm is falling well behind a key competitor.
6.06%
EPS growth under 50% of QRVO's 309.66%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
6.19%
Diluted EPS growth under 50% of QRVO's 301.58%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.40%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.39%
Reduced diluted shares while QRVO is at 3.53%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth of 0.00% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
15.35%
OCF growth under 50% of QRVO's 320.95%. Michael Burry might suspect questionable revenue recognition or rising costs.
14.67%
FCF growth under 50% of QRVO's 282.99%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
55.93%
10Y revenue/share CAGR under 50% of QRVO's 122.67%. Michael Burry would suspect a lasting competitive disadvantage.
27.00%
5Y revenue/share CAGR under 50% of QRVO's 122.67%. Michael Burry would suspect a significant competitive gap or product weakness.
20.87%
3Y revenue/share CAGR under 50% of QRVO's 61.39%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
47.63%
10Y OCF/share CAGR under 50% of QRVO's 6952.14%. Michael Burry would worry about a persistent underperformance in cash creation.
55.81%
Below 50% of QRVO's 6952.14%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
27.49%
3Y OCF/share CAGR under 50% of QRVO's 574.03%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
150.27%
Similar net income/share CAGR to QRVO's 138.87%. Walter Schloss would see parallel tailwinds or expansions for both firms.
171.55%
5Y net income/share CAGR 1.25-1.5x QRVO's 138.87%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
66.59%
3Y net income/share CAGR above 1.5x QRVO's 16.61%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
34.68%
Below 50% of QRVO's 728.25%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.06%
Below 50% of QRVO's 728.25%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.24%
Below 50% of QRVO's 343.41%. Michael Burry suspects a serious short-term disadvantage in building book value.
526.04%
Dividend/share CAGR of 526.04% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
192.90%
Dividend/share CAGR of 192.90% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.12%
3Y dividend/share CAGR of 66.12% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
9.87%
AR growth is negative/stable vs. QRVO's 21.03%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
5.64%
We show growth while QRVO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.88%
Asset growth above 1.5x QRVO's 0.95%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.05%
Positive BV/share change while QRVO is negative. John Neff sees a clear edge over a competitor losing equity.
6.70%
Debt growth far above QRVO's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.44%
R&D dropping or stable vs. QRVO's 7.63%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.